From: The role of longitudinal cohort studies in epigenetic epidemiology: challenges and opportunities
Cohort | DNA analysis time points | Tissue | Form of DNA methylation analysis | Loci | Exposure (if applicable) | Outcome (if applicable) | n | References |
---|---|---|---|---|---|---|---|---|
EPIC & Breakthrough Generations Study & KConFab | 1 | Peripheral blood | Pyrosequencing | ATM, LINE-1 | Â | Breast cancer | 1,381 | [112] |
EPIC-Lung | 1 | Peripheral blood | Pyrosequencing | CDKN2A RASSF1A, GSTP1, MTHFR, MGMT | B vitamins, smoking | Lung cancer | 93 | [18] |
EPIC-Norfolk | 1 | Tumor tissue | Pyrosequencing | MLH1 | Â | Colorectal cancer | 185 | [21] |
EPIC-EURGAST | 1 | Tumor tissue | Pyrosequencing | CHRNA3, DOK1, MGMT, RASSF1A, p14ARF, CDH1, MLH1, ALDH2, GNMT, MTHFR | Â | Gastric cancer | 162 | [22] |
Iowa Women's Health Study | 1 | Tumor tissue | MethyLight | CpG island methylator phenotype | Smoking | Colorectal cancer | 555 | [23] |
Netherlands Cohort Study | 1 | Tumor tissue | Methylation specific PCR | CACNA1G, IGF2, NEUROG1, RUNX3, SOCS1 | Body size and physical activity | Colorectal cancer | 734 | [113] |
New York University Women's Health Study | 1 | Peripheral blood | Methylation specific PCR | RASSF1A, GSTP1, APC, RARβ2 |  | Breast cancer | 200 | [19] |
Northern Sweden Health and Disease Study | 1 | Tumor tissue | MethyLight | CpG island methylator phenotype | B vitamins | Colorectal cancer | 570 | [24] |
Nurse's Health Study | 1 | Tumor tissue | MethyLight | CACNA1G, CDKN2A, CRABP1, IGF2, MLH1, NEUROG1, RUNX3, SOCS1CHFR, HIC1, IGFBP3, MGMT, MINT-1, MINT-31, p14, WRN | B vitamins and alcohol | Colorectal cancer | 761 | [25] |
Shanghai Women's Health Study | 1 | Peripheral blood | Pyrosequencing | Alu, LINE-1 | Â | Gastric cancer | 576 | [20] |